(Q34881170)

5 August 2017

1 reference

title

Pathogenesis of drug-induced exanthems (English)

1 reference

5 August 2017

Pichler W

1

1 reference

5 August 2017

Yawalkar N

series ordinal

2

1 reference

5 August 2017

Schmid S

series ordinal

3

1 reference

5 August 2017

Helbling A

series ordinal

4

1 reference

5 August 2017

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

57

1 reference

5 August 2017

884-893

1 reference

5 August 2017

10

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

5 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Role of T cells in drug allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

T-cell involvement in drug-induced acute generalized exanthematous pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

T cell immune responses to haptens. Structural models for allergic and autoimmune reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Allergic and autoimmune reactions to xenobiotics: how do they arise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Adverse drug reactions in Sjögren's syndrome. Frequent allergic reactions and a specific trimethoprim-associated systemic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Predictive drug allergy testing: an alternative viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Cellular and molecular pathophysiology of cutaneous drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Recent advances in the pathology of cutaneous drug eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Perforin: more than just an effector molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

High IL-5 production by human drug-specific T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Acute generalized exanthematous pustulosis. Analysis of 63 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Delayed hypersensitivity drug reactions diagnosed by patch testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Patch testing in systemic drug eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Lymphocyte activation in cutaneous drug reactions.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

T cell involvement in cutaneous drug eruptions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Morbilliform eruptions caused by penicillin. A study by electron microscopy and immunologic tests

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced with the use of antibiotics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneousallergic drug reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Distinct serum cytokine levels in drug- and measles-induced exanthema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

The use of skin testing in the investigation of cutaneous adverse drug reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Skin and laboratory tests in amoxicillin- and penicillin-induced morbilliform skin eruption

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Drug-induced hypersensitivity nephritis: lymphocyte stimulation testing and renal biopsy in 10 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

Lymphocyte transformation test in drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.02161.X

7 January 2021

10.1034/J.1398-9995.2002.02161.X

Identifiers

DOI

1 reference

5 August 2017

1 reference